The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination

Mostrar otras versiones (1)

As of March 2022, there have been over 450 million reported SARS-CoV-2 cases worldwide, and more than 4 billion people have received their primary series of a COVID-19 vaccine. In order to longitudinally track SARS-CoV-2 antibody levels in people after vaccination or infection, a large-scale COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Forgacs, David, Moraes, Vanessa S., Hanley, Hannah B., Gattiker, Jasper L., Jefferson, Alexandria M., Ross, Ted M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936119/
https://www.ncbi.nlm.nih.gov/pubmed/35313572
http://dx.doi.org/10.1101/2022.03.16.484099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936119/
https://www.ncbi.nlm.nih.gov/pubmed/35313572
http://dx.doi.org/10.1101/2022.03.16.484099

Ejemplares similares